Regeneron Pharmaceuticals

REGN

Market cap $60.8B

622 hedge funds and large institutions have $25B invested in Regeneron Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 239 increasing their positions, 211 reducing their positions, and 59 closing their positions.

New

Increased

Maintained

Reduced

Closed

2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

622

Holders Change

Holders Change %

+0.65%

% of All Funds

14.26%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.28%

New

Increased

239

Reduced

211

Closed

Calls

$566M

Puts

$893M

Net Calls

-$328M

Net Calls Change

-$60.8M

Top Buyers

1	Harris Associates Chicago, Illinois	$1.09B
2	Capital World Investors Los Angeles, California	$2.09B
3	AllianceBernstein Nashville, Tennessee	$260M
4	Loomis, Sayles & Company Boston, Massachusetts	$1.14B
5	Janus Henderson Group London, United Kingdom	$622M

Top Sellers

1	Fidelity Investments Boston, Massachusetts	$1.48B
2	O OrbiMed New York	$129M
3	JIM Jupiter Investment Management London, United Kingdom	$31.7M
4	Deutsche Bank Frankfurt Am Main Ge, Germany	$273M
5	D.E. Shaw & Co New York	$112M